1-2 of 2
John J. Farrell, PhD
Close
Sort by
Journal Articles

Response of Patients with Transfusion-Dependent β-Thalassemia (TDT) to Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-Thalassemia) Gene Therapy Based on HBB Genotype and Disease Genetic Modifiers

Mark C. Walters, MD, David H.K. Chui, MD FRCPC, John J Farrell, PhD, Ashutosh Lal, MD, Franco Locatelli, MD PhD, Janet L. Kwiatkowski, MD MSCE, John B. Porter, MA, MD, FRCP, FRCPath, Martin G. Sauer, MD, Isabelle Thuret, MD, Suradej Hongeng, MD, Andreas E. Kulozik, MD PhD, Adrian J. Thrasher, MBBS, PhD FMedSci, Evangelia Yannaki, MD, Julia Yang, Dustin Whitney, PhD, Alexandria Petrusich, Richard A. Colvin, MD PhD, Alexis A. Thompson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–3.
https://doi.org/10.1182/blood-2020-137642
Published: 2020
Journal Articles

BCL11A enhancer Haplotypes Are Associated with the Distribution of HbF in Arab-Indian and African Haplotype Sickle Cell Anemia but Not the Different Population Levels of HbF

Paola Sebastiani, PhD, John J. Farrell, PhD, Shuai Wang, MS, Heather L Edward, BA, Heather M. Shappell, BS, Harold T. Bae, PhD, Clinton T. Baldwin, PhD, A. M. Al-Rubaish, MD, Zaki Naserullah, MD, Ahmed Alsuliman, MD, Pradeep K. Patra, PhD, Lindsay A. Farrer, PhD, David H.K. Chui, MD, Abdulrahman Alsultan, MD, Duyen A. Ngo, MD, Haifa Kathrin Al-Ali, MD, Martin H. Steinberg, MD
Journal: Blood
Blood (2014) 124 (21): 4066.
https://doi.org/10.1182/blood.V124.21.4066.4066
Published: 2014